1,487 results on '"Fiorucci, Stefano"'
Search Results
2. The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer
3. Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases
4. Bile acids and bile acid activated receptors in the treatment of Covid-19
5. Immunology of bile acids regulated receptors
6. Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH
7. Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis
8. Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease
9. Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders
10. Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis.
11. Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments.
12. Current Landscape and Evolving Therapies for Primary Biliary Cholangitis.
13. Linking liver metabolic and vascular disease via bile acid signaling
14. The Pharmacology of Bile Acids and Their Receptors
15. Chenodeoxycholic Acid: An Update on Its Therapeutic Applications
16. Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders
17. A microbial derived bile acid acts as GPBAR1 agonist and RORγt inverse agonist and reverses inflammation in inflammatory bowel disease
18. Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
19. Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis
20. Inverse Virtual Screening for the rapid re-evaluation of the presumed biological safe profile of natural products. The case of steviol from Stevia rebaudiana glycosides on farnesoid X receptor (FXR)
21. Bile Acid Signaling in Inflammatory Bowel Diseases
22. BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile.
23. Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders
24. Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease
25. Bile acids and bile acid activated receptors in the treatment of Covid-19
26. GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis
27. Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
28. The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer
29. Bile Acids Serve As Endogenous Antagonists Of The Leukemia Inhibitory Factor (LIF) Receptor in Oncogenesis
30. SNK @ DANKMEMES: Leveraging Pretrained Embeddings for Multimodal Meme Detection
31. Synthesis and characterization of well-defined poly(2-deoxy-2-methacrylamido-d-glucose) and its biopotential block copolymers via RAFT and ROP polymerization
32. Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities
33. A β-Oxidation-Resistant Lipoxin A4 Analog Treats Hapten-Induced Colitis by Attenuating Inflammation and Immune Dysfunction
34. Interaction of a Selective Cyclooxygenase-2 Inhibitor with Aspirin and NO-Releasing Aspirin in the Human Gastric Mucosa
35. Nanotraps with biomimetic surface as decoys for chemokines
36. NCX-1015, a Nitric-Oxide Derivative of Prednisolone, Enhances Regulatory T Cells in the Lamina Propria and Protects against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in Mice
37. Proteinase-Activated Receptor 2 is an Anti-Inflammatory Signal for Colonic Lamina Propria Lymphocytes in a Mouse Model of Colitis
38. An NO Derivative of Ursodeoxycholic Acid Protects against Fas-Mediated Liver Injury by Inhibiting Caspase Activity
39. Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders
40. Chenodeoxycholic Acid: An Update on Its Therapeutic Applications
41. The Pharmacology of Bile Acids and Their Receptors
42. Theonella: A Treasure Trove of Structurally Unique and Biologically Active Sterols
43. Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
44. Receptor-ligand interactions: Advanced biomedical applications
45. New brominated flame retardants and their metabolites as activators of the pregnane X receptor
46. Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1
47. Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders
48. The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV
49. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
50. Diethylstilbestrol-scaffold-based pregnane X receptor modulators
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.